Search Results - "Moremi, K.E."

Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants by Moremi, K.E., Scott, C.J., de Jager, L.J., Pienaar, R., Zemlin, A.E., Kotze, M.J.

Get full text

MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the point-of-care by Mampunye, I., Grant, K.A., Peeters, A.V., Torrorey-Sawe, R., French, D.J., Moremi, K.E., Kidd, M., van Eeden, P.C., Pienaar, F.M., van der Merwe, N.C., Kotze, M.J.

Get full text

P117 - Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants by Moremi, K.E., Scott, C.J., de Jager, L.J., Pienaar, R., Zemlin, A.E., Kotze, M.J.

Get full text

Metachronous Onset of Breast and Bladder Cancer Associated with the BRCA2 c.8162delG Founder Mutation Detected in a Patient with a Low MammaPrint Recurrence Risk by Mampunye, L, Moremi, K.E, Torrorey-Sawe, R, Grant, K.A, Kotze, M.J

“…Restricting genetic screening programs to cancer patients fulfilling high-risk criteria may limit the identification of genes with pleiotropic function…”
Get full text

P032 - MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the point-of-care by Mampunye, I., Grant, K.A., Peeters, A.V., Torrorey-Sawe, R., French, D.J., Moremi, K.E., Kidd, M., van Eeden, P.C., Pienaar, F.M., van der Merwe, N.C., Kotze, M.J.

Get full text